Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Buprenorphine TDS (Transdermal Delivery System) 5, 10 and 20 Applied Every 7 Days for Sixty Days vs. 5 mg Oxycodone/325 mg Acetaminophen Tablets q6h Prn vs. Placebo in Patients With Chronic Low Back Pain

NCT00315874 is registered in ClinicalTrials.gov with Purdue Pharma LP as lead sponsor.

NCT NCT00315874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00315874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Buprenorphine TDS (Transdermal Delivery System) 5, 10 and 20 Applied Every 7 Days for Sixty Days vs. 5 mg Oxycodone/325 mg Acetaminophen Tablets q6h Prn vs. Placebo in Patients With Chronic Low Back Pain
Lead sponsor
Purdue Pharma LP
Phase
Phase 3
Overall status
Completed
Start date
April 30, 1997
Completion date
January 31, 1998
Enrollment
225
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

back pain